Master Switch for Blood Cell Development Detected
With respect to the development of T-cells, Dr. Rosenbauer and colleagues could also show that the master switch is part of the wnt-signalling pathway. This pathway plays a crucial role in the healthy development of complex organisms. It reaches from the cell surface down into the cell nucleus with the genetic control station. If signals cannot be transmitted correctly via this pathway malformations or tumours develop. During T-cell development, this pathway normally is switched off. Thus, the master switch URE turns off the gene regulator PU.1. However, if this signalling pathway is disturbed, PU.1 is not turned off properly and T-cells cannot mature. "The deregulation of PU.1 prepares the platform for further mutations in the blood stem cells and the precursor cells, respectively, and thus for the outbreak of various forms of leukemia", so Dr. Rosenbauer. Now, together with clinicians from the Charité Medical School Berlin, they plan to study the blood of leukemia patients to see whether the findings in mice also hold true for blood cell development in humans.
* Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1
Frank Rosenbauer1,2,9, Bronwyn M Owens1,9, Li Yu3,8, Joseph R Tumang4, Ulrich Steidl1, Jeffery L Kutok5, Linda K Clayton6, Katharina Wagner1,8, Marina Scheller2, Hiromi Iwasaki7, Chunhui Liu3, Björn Hackanson3, Koichi Akashi7, Achim Leutz2, Thomas L Rothstein4, Christoph Plass3 & Daniel G Tenen1
1Harvard Institutes of Medicine and Harvard Stem Cell Institute, Room 954, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA. 2Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, 13092 Berlin, Germany. 3Internal Medicine, Division of Hematology/Oncology, The Ohio State University, Columbus, Ohio,USA. 4Department of Medicine, Evans Memorial Department of Clinical Research, Boston University Medical Center, Boston, Massachusetts, USA. 5Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. 6Laboratory of Immunobiology and 7Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. 8Present addresses: Department of Hematology, Hemostaseology and Oncology, Hannover Medical School, University of Hannover, Hannover, Germany (K.W.); Department of Hematology, 301 General Hospital of PLA, Beijing, China (L.Y.). 9These authors contributed equally to this work. Correspondence should be addressed to F.R. (f.rosenbauer@mdc-berlin.de) or D.G.T. (dtenen@bidmc.harvard.edu).
Press and Public Affairs
Max Delbrück Center for Molecular Medicine(MDC) Berlin-Buch
Barbara Bachtler
Robert-Rössle-Str. 10
13125 Berlin
Phone: +49/30/9406-38 96
Fax.: +49/30/9406-38 33
e-mail: bachtler@mdc-berlin.de
http://www.mdc-berlin.de
